188 related articles for article (PubMed ID: 2147689)
1. The cytotoxic action of diphtheria toxin and its degradation in intact Vero cells are inhibited by bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase.
Umata T; Moriyama Y; Futai M; Mekada E
J Biol Chem; 1990 Dec; 265(35):21940-5. PubMed ID: 2147689
[TBL] [Abstract][Full Text] [Related]
2. Japanese encephalitis virus infection in Vero cells: the involvement of intracellular acidic vesicles in the early phase of viral infection was observed with the treatment of a specific vacuolar type H+-ATPase inhibitor, bafilomycin A1.
Nawa M
Microbiol Immunol; 1997; 41(7):537-43. PubMed ID: 9272699
[TBL] [Abstract][Full Text] [Related]
3. Cell penetration of diphtheria toxin. Reduction of the interchain disulfide bridge is the rate-limiting step of translocation in the cytosol.
Papini E; Rappuoli R; Murgia M; Montecucco C
J Biol Chem; 1993 Jan; 268(3):1567-74. PubMed ID: 8420931
[TBL] [Abstract][Full Text] [Related]
4. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells.
Yoshimori T; Yamamoto A; Moriyama Y; Futai M; Tashiro Y
J Biol Chem; 1991 Sep; 266(26):17707-12. PubMed ID: 1832676
[TBL] [Abstract][Full Text] [Related]
5. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPases, inhibits the receptor-mediated endocytosis of asialoglycoproteins in isolated rat hepatocytes.
Harada M; Sakisaka S; Yoshitake M; Kin M; Ohishi M; Shakado S; Mimura Y; Noguchi K; Sata M; Tanikawa K
J Hepatol; 1996 May; 24(5):594-603. PubMed ID: 8773916
[TBL] [Abstract][Full Text] [Related]
6. [3H]Bafilomycin as a probe for the transmembrane proton channel of the osteoclast vacuolar H(+)-ATPase.
Mattsson JP; Keeling DJ
Biochim Biophys Acta; 1996 Apr; 1280(1):98-106. PubMed ID: 8634321
[TBL] [Abstract][Full Text] [Related]
7. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.
Mattsson JP; Väänänen K; Wallmark B; Lorentzon P
Biochim Biophys Acta; 1991 Jun; 1065(2):261-8. PubMed ID: 1647821
[TBL] [Abstract][Full Text] [Related]
8. Bafilomycin A1 inhibits IL-1-stimulated proteoglycan degradation by chondrocytes without affecting stromelysin synthesis.
Yocum SA; Lopresti-Morrow LL; Gabel CA; Milici AJ; Mitchell PG
Arch Biochem Biophys; 1995 Feb; 316(2):827-35. PubMed ID: 7864640
[TBL] [Abstract][Full Text] [Related]
9. Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells.
Papini E; Bugnoli M; De Bernard M; Figura N; Rappuoli R; Montecucco C
Mol Microbiol; 1993 Jan; 7(2):323-7. PubMed ID: 8446034
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cell growth by bafilomycin A1, a selective inhibitor of vacuolar H(+)-ATPase.
Ohkuma S; Shimizu S; Noto M; Sai Y; Kinoshita K; Tamura H
In Vitro Cell Dev Biol Anim; 1993 Nov; 29A(11):862-6. PubMed ID: 8167902
[TBL] [Abstract][Full Text] [Related]
11. Vacuolar acidification and bafilomycin-sensitive proton translocating ATPase in human epidermal Langerhans cells.
Girolomoni G; Stone DK; Bergstresser PR; Cruz PD
J Invest Dermatol; 1991 May; 96(5):735-41. PubMed ID: 1827137
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of vacuolar-type H(+)-ATPase suppresses proliferation of cultured cells.
Manabe T; Yoshimori T; Henomatsu N; Tashiro Y
J Cell Physiol; 1993 Dec; 157(3):445-52. PubMed ID: 8253855
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of bafilomycin A1 derivatives as inhibitors of vacuolar H+-ATPase.
Gagliardi S; Gatti PA; Belfiore P; Zocchetti A; Clarke GD; Farina C
J Med Chem; 1998 May; 41(11):1883-93. PubMed ID: 9599238
[TBL] [Abstract][Full Text] [Related]
14. Relative roles of Na+/H+ exchange and vacuolar-type H+ ATPases in regulating cytoplasmic pH and function in murine peritoneal macrophages.
Swallow CJ; Grinstein S; Sudsbury RA; Rotstein OD
J Cell Physiol; 1993 Dec; 157(3):453-60. PubMed ID: 8253856
[TBL] [Abstract][Full Text] [Related]
15. Induction of neurite outgrowth of PC12 cells by an inhibitor of vacuolar H(+)-ATPase, bafilomycin A1.
Tamura H; Ohkuma S
FEBS Lett; 1991 Dec; 294(1-2):51-5. PubMed ID: 1660409
[TBL] [Abstract][Full Text] [Related]
16. Effects of bafilomycin A1 on functional capabilities of LPS-activated alveolar macrophages.
Bidani A; Heming TA
J Leukoc Biol; 1995 Feb; 57(2):275-81. PubMed ID: 7852842
[TBL] [Abstract][Full Text] [Related]
17. Retrograde transport from the pre-Golgi intermediate compartment and the Golgi complex is affected by the vacuolar H+-ATPase inhibitor bafilomycin A1.
Palokangas H; Ying M; Väänänen K; Saraste J
Mol Biol Cell; 1998 Dec; 9(12):3561-78. PubMed ID: 9843588
[TBL] [Abstract][Full Text] [Related]
18. Destruxin B, a specific and readily reversible inhibitor of vacuolar-type H(+)-translocating ATPase.
Muroi M; Shiragami N; Takatsuki A
Biochem Biophys Res Commun; 1994 Dec; 205(2):1358-65. PubMed ID: 7802670
[TBL] [Abstract][Full Text] [Related]
19. Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells.
Guinea R; Carrasco L
J Virol; 1995 Apr; 69(4):2306-12. PubMed ID: 7884876
[TBL] [Abstract][Full Text] [Related]
20. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, blocks lysosomal cholesterol trafficking in macrophages.
Furuchi T; Aikawa K; Arai H; Inoue K
J Biol Chem; 1993 Dec; 268(36):27345-8. PubMed ID: 8262974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
